Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.
about
Substance abuse and schizophrenia: pharmacotherapeutic interventionGene-environment interplay between cannabis and psychosisRevisiting the 'self-medication' hypothesis in light of the new data linking low striatal dopamine to comorbid addictive behaviorAre executive function and impulsivity antipodes? A conceptual reconstruction with special reference to addictionBiomarker Case-Detection and Prediction with Potential for Functional Psychosis Screening: Development and Validation of a Model Related to Biochemistry, Sensory Neural Timing and End Organ Performance.Schizophrenia and the cannabinoid receptor type 1 (CB1): association study using a single-base polymorphism in coding exon 1A neurobiological basis for substance abuse comorbidity in schizophreniaMeasuring readiness-to-change substance misuse among psychiatric outpatients: I. Reliability and validity of self-report measuresManagement of persons with co-occurring severe mental illness and substance use disorder: program implications.The role of cannabinoid 1 receptor expressing interneurons in behavior.GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders.Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia.Managing addiction as a chronic condition.Increased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuseThe impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample.A cross-sectional study of patients with and without substance use disorders in Community Mental Health Centres.Substance abuse and cognitive functioning in schizophrenia.Cannabis use and psychosis: a review of clinical and epidemiological evidence.[Prevalence of psychosis/substance abuse comorbidity. Clinical-epidemiological findings from different treatment settings in a large German city]Cannabis and psychopathology : update 2004.Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis.The varied outcomes of schizophrenia.Perceived reasons for and consequences of substance abuse among patients with psychosisSubstance abuse in first-episode schizophrenic patients: a retrospective studyImpulsivity and sensation seeking in alcohol abusing patients with schizophrenia.Validation of the revised Problems Assessment for Substance Using Psychiatric PatientsBehavioral Interventions for Individuals Dually-Diagnosed with a Severe Mental Illness and a Substance Use Disorder.Comorbid substance abuse and brain morphology in recent-onset psychosisNeuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories.Treatment of the special patient with schizophrenia.Latent class analysis of discordance between results of drug use assessments in the CATIE data.A randomized trial of clozapine vs. other antipsychotics for cannabis use disorder in patients with schizophrenia.Integrated services for treatment of schizophrenic substance abusers: demographics, symptoms, and substance abuse patterns.Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders.Schizophrenia and substance abuse: prevalence issues.Family intervention for co-occurring substance use and severe psychiatric disorders: participant characteristics and correlates of initial engagement and more extended exposure in a randomized controlled trial.Examination of the inventory of drug use consequences with individuals with serious and persistent mental illness and co-occurring substance use disorders.The Potential Role of Long-acting Injectable Antipsychotics in People with Schizophrenia and Comorbid Substance Use.Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disorders.
P2860
Q24621711-B5C0444F-99C7-40E9-B4F7-C0A32723F976Q24643510-6B831BF5-D115-4E80-BA4C-61808834ECF8Q26801102-2742E193-5050-4922-BBAF-41841A699FF2Q26824038-CD88E44F-F572-4272-B99D-C7A4248D25D0Q27303747-DFD63572-16B9-4450-A8EE-1B59CAB939B6Q28216128-65E51104-8A70-4462-AE9C-677ECEC53321Q28347063-1E385010-A595-4668-9A70-5ED9BA11D037Q28361451-46BE5FCD-2443-4946-B863-21E0F34E90A8Q30367085-8889E750-4A97-4391-97B0-634A4FC6506BQ30417825-6980E34B-4B78-4E68-9C86-29C86D9AC1AEQ30479407-EABFA5BB-C3F4-47D5-9CB8-7C7B52BAC2F1Q30558464-D91777D9-395D-4D49-8550-B91890AD44ABQ33223628-4C96DA4D-A58C-48FC-B0C1-8ABC790D1946Q33553127-F5D0D613-EED8-4AE2-AF6D-BCC4FBCFD3B8Q33590705-C54D0B54-49FB-424A-88C6-2470CAF54F43Q33641039-31B1BFEE-D9AD-457F-A2FE-F9EFE4E9BE74Q33909153-A8AB176C-3381-4035-902D-71158D048DA2Q33921874-52752155-E4DE-44CE-8DFB-58C3A5445C03Q33933884-145C9E0C-F6A3-4F54-B92F-F1B946875C7AQ34021649-8A8A6594-B1F2-4BF0-8353-73E9FBFDF61DQ34180323-C0B997F7-C223-422E-A478-3BA8ED7522E7Q34235419-27EDAB36-C213-4B14-86DA-DF6284AA5638Q34417104-043E4886-96A0-482C-A38B-E8169D4EFF51Q34516286-712052A9-8170-49E5-BEB1-0CF697B684C7Q34537645-9D3D4B34-45AF-44A4-82D0-344F25B3352EQ34689535-C91DD70E-F5FF-44A6-8E71-26CF811B3719Q34696382-807D162A-248A-4F78-B317-DDB9EA90D788Q34713369-4833DA76-EDD6-47D3-A79A-0B355A277559Q34901749-68FFDA84-7299-40E9-A946-8464B5F61A43Q35164053-5C0BA89A-CC30-4C31-BC59-43646EE1B605Q35236370-F3EB3522-C515-4FE3-A1E2-032300296667Q35491819-9128D954-8860-44CA-B1F8-49FBA45299D7Q35529636-BDE7ED55-A0B3-4AFE-9BC8-B6657158FCE5Q35531488-A15CF466-27C0-41D9-A37A-6BDA7FC5CC18Q35536880-EB46F99E-4D0E-4610-A70A-4D7F2EB8148FQ35632628-D0FF553E-C84D-4AB7-9486-9AF692D07CC9Q35684118-B1AFE72C-DAEC-4D4C-8624-E92DDC228F5DQ35775736-2EBA2EBF-E5BC-4A3A-886C-559BF356586BQ36059843-6DB0331B-C506-4EE0-AF6B-81AAC0974CB9Q36083997-386FFBDC-9BD1-4354-BB3C-6301EFA9E7D1
P2860
Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.
@en
Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.
@nl
type
label
Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.
@en
Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.
@nl
prefLabel
Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.
@en
Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.
@nl
P2093
P356
P1476
Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.
@en
P2093
Bellack AS
Levinson DF
Morrison RL
Yadalam KG
Yarnold PR
P356
10.1093/SCHBUL/16.1.31
P407
P577
1990-01-01T00:00:00Z